Binar Asrining Dhiani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Binar Asrining Dhiani has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Youcef Mehellou
Cardiff University
4 shared publications - Asmiyenti Djaliasrin Djalil
Department of Pharmacy, Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto
2 shared publications Chuenchit Boonchird
Faculty of Science, Department of Biotechnology, Mahidol University, Bangkok, Thailand
2 shared publicationsHachemi Kadri
School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UK
2 shared publicationsJutarmas Jungsukcharoen
A Faculty of Science, Program in Biotechnology , Chulalongkorn University , Bangkok , Thailand
2 shared publications- Mubarak A. Alamri
Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia
2 shared publications
Latest Publications
- Open Access
- 20 September 2025
- Published by Rangsit University in Journal of Current Science and Technology
- Vol. 15 (4) , 143
Application of Riboflavin and Curcumin as Natural Photosensitizers for Antimicrobial Photodynamic Inactivation against Staphylococcus aureus: A Study for Skin Disease
Atopic Dermatitis (AD) and Actinic Keratosis (AK) are becoming increasingly prevalent in developing countries, including Indonesia. Staphylococcus aureus, a common microorganism associated with both conditions, presents treatment challenges due to the increasing antibiotic resistance and associated side effects. Photodynamic Inactivation (PDI), which employs natural photosensitizers such as riboflavin and curcumin in combination with Omega Light LED-a technology commonly used in aesthetic treatments-offers a potential alternative. In this study, riboflavin and curcumin were applied separately at a concentration of 0.015% (w/v) and irradiated with red (λ = 640 nm), blue (λ = 423 nm), or green (λ = 532 nm) light using an Omega Light LED device (O'melon). Cell viability was assessed using an ELISA reader at 595 nm after irradiation durations of 10, 30, and 60 minutes. Skin toxicity was predicted using Toxtree 3.1.0, Pred-Skin 3.0, and pkCSM web-based tools. Results showed that the photosensitizers without irradiation were not cytotoxic to Staphylococcus aureus. However, the combination of blue light and photosensitizers significantly inhibited bacterial viability. Riboflavin achieved 49.0±4.8% inhibition within 10 minutes, indicating a rapid but transient effect, whereas curcumin elicited a slower yet sustained antibacterial response, achieving 34.2 ± 1.6% inhibition after 30 minutes. Computational toxicity predictions suggested no clear evidence of skin irritation; however, a potential for skin sensitization remains. These findings support the potential of riboflavin- and curcumin-based PDI using Omega Light LED as a promising non-antibiotic approach for managing Staphylococcus aureus infections in AD and AK.
- 20 September 2025
- Published by Rangsit University in Journal of Current Science and Technology
- Vol. 15 (4) , 143
Open AccessApplication of Riboflavin and Curcumin as Natural Photosensitizers for Antimicrobial Photodynamic Inactivation against Staphylococcus aureus: A Study for Skin Disease
Atopic Dermatitis (AD) and Actinic Keratosis (AK) are becoming increasingly prevalent in developing countries, including Indonesia. Staphylococcus aureus, a common microorganism associated with both conditions, presents treatment challenges due to the increasing antibiotic resistance and associated side effects. Photodynamic Inactivation (PDI), which employs natural photosensitizers such as riboflavin and curcumin in combination with Omega Light LED-a technology commonly used in aesthetic treatments-offers a potential alternative. In this study, riboflavin and curcumin were applied separately at a concentration of 0.015% (w/v) and irradiated with red (λ = 640 nm), blue (λ = 423 nm), or green (λ = 532 nm) light using an Omega Light LED device (O'melon). Cell viability was assessed using an ELISA reader at 595 nm after irradiation durations of 10, 30, and 60 minutes. Skin toxicity was predicted using Toxtree 3.1.0, Pred-Skin 3.0, and pkCSM web-based tools. Results showed that the photosensitizers without irradiation were not cytotoxic to Staphylococcus aureus. However, the combination of blue light and photosensitizers significantly inhibited bacterial viability. Riboflavin achieved 49.0±4.8% inhibition within 10 minutes, indicating a rapid but transient effect, whereas curcumin elicited a slower yet sustained antibacterial response, achieving 34.2 ± 1.6% inhibition after 30 minutes. Computational toxicity predictions suggested no clear evidence of skin irritation; however, a potential for skin sensitization remains. These findings support the potential of riboflavin- and curcumin-based PDI using Omega Light LED as a promising non-antibiotic approach for managing Staphylococcus aureus infections in AD and AK.
- Open Access
- 30 April 2023
- Published by Universitas Airlangga in Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
- Vol. 10 (1) , 11-21
Molecular Docking of Bicycloproline Derivative Synthetic Compounds on Envelope Protein: Anti-SARS-CoV-2 Drug Discovery
Background: Although a SARS-CoV-2 vaccine is readily available, new cases of COVID-19 are still occurring. New drug discovery is needed to treat COVID-19. Protein E is one of the potential targets. Two synthetic compounds of bicycloproline derivatives have the potential to be developed. Objective: This study aimed to estimate the interaction of bicycloproline compounds to protein E in-silico. Methods: There were two bicycloproline-derived compounds, MI-09 and MI-30, used in docking. Remdesivir was used as a reference ligand. The crystal structure of the E protein was created using homology modeling, while the test compound was drawn using the Marvin Sketch. MOE 2022.02 and BDS 2021 were used for docking and visualization processes. Results: The pentamer of the SARS-CoV-2 E protein obtained a clash score (1.06); poor rotatomer (0.00%); favored rotamers (98.11%); Ramachandran favored (96.43%); Ramachandran outlier (1.78%); Rama Z-score (-1.08); and mol probity (1.04). Research shows promising inhibition potential of the MI-09 and MI-30. The MI-30 has the best binding energy of -10.3326 kcal/mol. Conclusion: The docking results show that MI-30 has potency as an inhibitor of protein E and can be developed in treating COVID-19. Further research is needed to confirm the result by in vitro and in vivo studies.
- 30 April 2023
- Published by Universitas Airlangga in Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
- Vol. 10 (1) , 11-21
Open AccessMolecular Docking of Bicycloproline Derivative Synthetic Compounds on Envelope Protein: Anti-SARS-CoV-2 Drug Discovery
Background: Although a SARS-CoV-2 vaccine is readily available, new cases of COVID-19 are still occurring. New drug discovery is needed to treat COVID-19. Protein E is one of the potential targets. Two synthetic compounds of bicycloproline derivatives have the potential to be developed. Objective: This study aimed to estimate the interaction of bicycloproline compounds to protein E in-silico. Methods: There were two bicycloproline-derived compounds, MI-09 and MI-30, used in docking. Remdesivir was used as a reference ligand. The crystal structure of the E protein was created using homology modeling, while the test compound was drawn using the Marvin Sketch. MOE 2022.02 and BDS 2021 were used for docking and visualization processes. Results: The pentamer of the SARS-CoV-2 E protein obtained a clash score (1.06); poor rotatomer (0.00%); favored rotamers (98.11%); Ramachandran favored (96.43%); Ramachandran outlier (1.78%); Rama Z-score (-1.08); and mol probity (1.04). Research shows promising inhibition potential of the MI-09 and MI-30. The MI-30 has the best binding energy of -10.3326 kcal/mol. Conclusion: The docking results show that MI-30 has potency as an inhibitor of protein E and can be developed in treating COVID-19. Further research is needed to confirm the result by in vitro and in vivo studies.
- 15 October 2019
- Published by Wiley in ChemBioChem
- Vol. 21 (5) , 638-643
The Cul4‐DDB1‐WDR3/WDR6 Complex Binds SPAK and OSR1 Kinases in a Phosphorylation‐Dependent Manner
SPAK and OSR1 are two protein kinases that play critical roles in regulating ion homeostasis. They are activated under osmotic stress through phosphorylation by their upstream WNK kinases at a conserved threonine site on their T‐loops. Additionally, WNK kinases phosphorylate SPAK and OSR1 at a highly conserved serine residue on their S‐motif, the function of which remains elusive. Using affinity pull down and mass spectrometry, we identified the E3 ubiquitin ligase complex Cullin 4‐DDB1‐WDR3/WDR6 as a binder to OSR1 kinase in a SPAK/OSR1 S‐motif phosphorylation‐dependent manner. This binding was found to be compromised by S‐motif phosphorylation following osmotic stress. Using proteasomal and neddylation inhibitors, we subsequently showed that OSR1 ubiquitylation was abolished under osmotic stress when its S‐motif is phosphorylated. These results provide the first example of an E3 ubiquitin ligase system that binds the OSR1 kinase and, thus, links the CRL4 complex to ion homeostasis.
- 15 October 2019
- Published by Wiley in ChemBioChem
- Vol. 21 (5) , 638-643
The Cul4‐DDB1‐WDR3/WDR6 Complex Binds SPAK and OSR1 Kinases in a Phosphorylation‐Dependent Manner
SPAK and OSR1 are two protein kinases that play critical roles in regulating ion homeostasis. They are activated under osmotic stress through phosphorylation by their upstream WNK kinases at a conserved threonine site on their T‐loops. Additionally, WNK kinases phosphorylate SPAK and OSR1 at a highly conserved serine residue on their S‐motif, the function of which remains elusive. Using affinity pull down and mass spectrometry, we identified the E3 ubiquitin ligase complex Cullin 4‐DDB1‐WDR3/WDR6 as a binder to OSR1 kinase in a SPAK/OSR1 S‐motif phosphorylation‐dependent manner. This binding was found to be compromised by S‐motif phosphorylation following osmotic stress. Using proteasomal and neddylation inhibitors, we subsequently showed that OSR1 ubiquitylation was abolished under osmotic stress when its S‐motif is phosphorylated. These results provide the first example of an E3 ubiquitin ligase system that binds the OSR1 kinase and, thus, links the CRL4 complex to ion homeostasis.
- 7 November 2018
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 10 (2) , 200-208
Phosphotyrosine prodrugs: design, synthesis and anti-STAT3 activity of ISS-610 aryloxy triester phosphoramidate prodrugs
The application of the aryloxy triester phosphoramidate prodrug technology to ISS-610-Met improves its ability to inhibit STAT3 in cells.
- 7 November 2018
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 10 (2) , 200-208
Phosphotyrosine prodrugs: design, synthesis and anti-STAT3 activity of ISS-610 aryloxy triester phosphoramidate prodrugs
The application of the aryloxy triester phosphoramidate prodrug technology to ISS-610-Met improves its ability to inhibit STAT3 in cells.
- 1 September 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 503 (3) , 1868-1873
C-terminal phosphorylation of SPAK and OSR1 kinases promotes their binding and activation by the scaffolding protein MO25
- 1 September 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 503 (3) , 1868-1873
C-terminal phosphorylation of SPAK and OSR1 kinases promotes their binding and activation by the scaffolding protein MO25
- 26 September 2017
- Published by Wiley in ChemMedChem
- Vol. 12 (20) , 1677-1686
WNK Signaling Inhibitors as Potential Antihypertensive Drugs
Since the discovery of WNK mutations that cause an inherited form of hypertension in humans, there has been increasing interest in targeting WNK signaling as a novel strategy for modulating blood pressure. This notion is now supported by numerous mouse models with impaired WNK signaling that exhibit reduced blood pressure. Biochemical analyses of the various protein components that make up this signaling pathway have identified a number of plausible molecular targets that are amenable to targeting by small molecules. To date, a selection of small‐molecule WNK signaling inhibitors have been identified and have shown promise in suppressing the activity of WNK signaling in cells and in animals. In this Minireview, we briefly discuss the WNK signaling pathway and provide an overview of the various druggable targets within this cascade, as well as the different WNK signaling inhibitors discovered to date.
- 26 September 2017
- Published by Wiley in ChemMedChem
- Vol. 12 (20) , 1677-1686
WNK Signaling Inhibitors as Potential Antihypertensive Drugs
Since the discovery of WNK mutations that cause an inherited form of hypertension in humans, there has been increasing interest in targeting WNK signaling as a novel strategy for modulating blood pressure. This notion is now supported by numerous mouse models with impaired WNK signaling that exhibit reduced blood pressure. Biochemical analyses of the various protein components that make up this signaling pathway have identified a number of plausible molecular targets that are amenable to targeting by small molecules. To date, a selection of small‐molecule WNK signaling inhibitors have been identified and have shown promise in suppressing the activity of WNK signaling in cells and in animals. In this Minireview, we briefly discuss the WNK signaling pathway and provide an overview of the various druggable targets within this cascade, as well as the different WNK signaling inhibitors discovered to date.
- Open Access
- 1 November 2016
- Published by Penerbit Universiti Sains Malaysia in Tropical Life Sciences Research
- Vol. 27 (Supp. 1) , 161-166
Screening of Potential Free Radicals Scavenger and Antibacterial Activities of Purwoceng (Pimpinella alpina Molk)
Purwoceng (Pimpinella alpina Molk) is a traditional medicinal plant used for its aphrodisiac values. This plant was originated Dieng Plateu, Central Java, Indonesia. Purwoceng has been reported to contain steroid, flavonoids, glycoside, saponins, tannins, and phenolic. Based on secondary metabolite compounds of Purwoceng herbs, a research need to be done to determine the other potential free radicals scavenger and antibacterial activities of Purwoceng. The objectives of this research are to screen the potential free radicals scavenger activity of in vitro using DPPH (1,1 diphenyl-2-picryl-hydrazil) radicals and NO• (nitric oxide) radicals, and antibacterial activity of Purwoceng. The extraction is done by a maceration method with petroleum ether, ethyl acetate, and ethanol solvent, respectively. Free radicals scavenger test was performed using DPPH radicals and NO• radicals, while antibacterial activity screening was performed using agar diffusion test. The results showed that ethyl acetate extract of Purwoceng has free radical scavenger activity with IC50 53.07 ppm lower than butylated hydroxytoluene. Ethyl acetate extract and ethanol extract of Purwoceng have antibacterial activity against Staphyloccus aureus, Escherichia coli, and MG42 bacterial isolate.
- 1 November 2016
- Published by Penerbit Universiti Sains Malaysia in Tropical Life Sciences Research
- Vol. 27 (Supp. 1) , 161-166
Open AccessScreening of Potential Free Radicals Scavenger and Antibacterial Activities of Purwoceng (Pimpinella alpina Molk)
Purwoceng (Pimpinella alpina Molk) is a traditional medicinal plant used for its aphrodisiac values. This plant was originated Dieng Plateu, Central Java, Indonesia. Purwoceng has been reported to contain steroid, flavonoids, glycoside, saponins, tannins, and phenolic. Based on secondary metabolite compounds of Purwoceng herbs, a research need to be done to determine the other potential free radicals scavenger and antibacterial activities of Purwoceng. The objectives of this research are to screen the potential free radicals scavenger activity of in vitro using DPPH (1,1 diphenyl-2-picryl-hydrazil) radicals and NO• (nitric oxide) radicals, and antibacterial activity of Purwoceng. The extraction is done by a maceration method with petroleum ether, ethyl acetate, and ethanol solvent, respectively. Free radicals scavenger test was performed using DPPH radicals and NO• radicals, while antibacterial activity screening was performed using agar diffusion test. The results showed that ethyl acetate extract of Purwoceng has free radical scavenger activity with IC50 53.07 ppm lower than butylated hydroxytoluene. Ethyl acetate extract and ethanol extract of Purwoceng have antibacterial activity against Staphyloccus aureus, Escherichia coli, and MG42 bacterial isolate.
- 3 June 2014
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 78 (6) , 917-926
Pueraria mirifica leaves, an alternative potential isoflavonoid source
We investigated the major leaf isoflavonoid contents of Pueraria mirifica from three different cultivars (PM-III, PM-IV, and PM-V) using reverse RP-HPLC analysis. The proportions and net levels of puerarin, daidzin, genistin, and daidzein in P. mirifica leaves were found to depend on the plant cultivar and to correlate with cultivation temperature and rainfall amount. The crude leaf-extracts were tested using the Yeast Estrogen Screen (YES) assay with both human estrogen receptors (hERα and hERβ). Their estrogenic activity was higher when determined by the YES system containing hERβ than that with hERα and was also higher when the Δsnq2 than the wildtype yeast was employed. The results open the possibility of selecting and cultivating certain P. mirifica cultivars at a farm scale to produce a sufficient supply of leaf material to act as a starting source for the commercial scale extraction of these major isoflavonoids.
- 3 June 2014
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 78 (6) , 917-926
Pueraria mirifica leaves, an alternative potential isoflavonoid source
We investigated the major leaf isoflavonoid contents of Pueraria mirifica from three different cultivars (PM-III, PM-IV, and PM-V) using reverse RP-HPLC analysis. The proportions and net levels of puerarin, daidzin, genistin, and daidzein in P. mirifica leaves were found to depend on the plant cultivar and to correlate with cultivation temperature and rainfall amount. The crude leaf-extracts were tested using the Yeast Estrogen Screen (YES) assay with both human estrogen receptors (hERα and hERβ). Their estrogenic activity was higher when determined by the YES system containing hERβ than that with hERα and was also higher when the Δsnq2 than the wildtype yeast was employed. The results open the possibility of selecting and cultivating certain P. mirifica cultivars at a farm scale to produce a sufficient supply of leaf material to act as a starting source for the commercial scale extraction of these major isoflavonoids.
- Open Access
- 15 June 2012
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 10 (2) , 46-1
DIFFERENTIAL ESTROGENIC ACTIVITY OF PUERARIA MIRIFICA LEAVES DETERMINED BY YEAST ESTROGEN SCREEN HARBORED HUMAN ESTROGEN RECEPTOR-A AND-B
DIFFERENTIAL ESTROGENIC ACTIVITY OF PUERARIA MIRIFICA LEAVES DETERMINED BY YEAST ESTROGEN SCREEN HARBORED HUMAN ESTROGEN RECEPTOR-A AND-B
- 15 June 2012
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 10 (2) , 46-1
Open AccessDIFFERENTIAL ESTROGENIC ACTIVITY OF PUERARIA MIRIFICA LEAVES DETERMINED BY YEAST ESTROGEN SCREEN HARBORED HUMAN ESTROGEN RECEPTOR-A AND-B
DIFFERENTIAL ESTROGENIC ACTIVITY OF PUERARIA MIRIFICA LEAVES DETERMINED BY YEAST ESTROGEN SCREEN HARBORED HUMAN ESTROGEN RECEPTOR-A AND-B
- Open Access
- 28 February 2012
- Published by Indonesian Journal of Pharmacy in Indonesian Journal of Cancer Chemoprevention
- Vol. 3 (1) , 358-363
Antiproliferative Effect of Chloroform Extract of Cangkring Leaves (Erythrina fusca Lour.) and Its Isolates against HeLa Cells
Cervical cancer is a type of cancer possessing the 3rd highest incidence among women worldwide. Today’s therapies against cancer are still ineffective, thus people are seeking for alternative method. Erythrina fusca Lour. has been used traditionally as anticancer. This experiment is conducted to study the ability of chloroform extract of E. fusca Lour. leaves and its isolates on HeLa cervical cancer cells. The cytotoxicity assay and doubling time assay were done using direct counting method, while the DNA staining assay was done using acrydine orange. The chloroform extract and isolate # 30 showed cytotoxic activity with IC50 of 16 and 5 µg/ml, respectively, while isolate # 2 and isolate # 8 didn’t. The effluent # 30 could not affect HeLa cells growth at the given concentration, but it might promote DNA fragmentation indicating apoptosis induction. The molecular mechanisms underlying these effects still need to be further explored.Keywords: Erythrina fusca Lour., isolate and effluent of chloroform extract, antiproliferative, cervical cancer
- 28 February 2012
- Published by Indonesian Journal of Pharmacy in Indonesian Journal of Cancer Chemoprevention
- Vol. 3 (1) , 358-363
Open AccessAntiproliferative Effect of Chloroform Extract of Cangkring Leaves (Erythrina fusca Lour.) and Its Isolates against HeLa Cells
Cervical cancer is a type of cancer possessing the 3rd highest incidence among women worldwide. Today’s therapies against cancer are still ineffective, thus people are seeking for alternative method. Erythrina fusca Lour. has been used traditionally as anticancer. This experiment is conducted to study the ability of chloroform extract of E. fusca Lour. leaves and its isolates on HeLa cervical cancer cells. The cytotoxicity assay and doubling time assay were done using direct counting method, while the DNA staining assay was done using acrydine orange. The chloroform extract and isolate # 30 showed cytotoxic activity with IC50 of 16 and 5 µg/ml, respectively, while isolate # 2 and isolate # 8 didn’t. The effluent # 30 could not affect HeLa cells growth at the given concentration, but it might promote DNA fragmentation indicating apoptosis induction. The molecular mechanisms underlying these effects still need to be further explored.Keywords: Erythrina fusca Lour., isolate and effluent of chloroform extract, antiproliferative, cervical cancer